http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-764122-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C47-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C403-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C403-00
filingDate 1955-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1956-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-764122-A
titleOfInvention The manufacture of ª ,ª unsaturated aldehydes
abstract The invention comprises the aldehydes [2,6,6 - trimethyl - cyclohexen - (2) - ylidine(1)] - acetaldehyde and [2,6,6 - trimethylcyclohexylidene - (1)] - acetaldehyde. These, and known a ,b -unsaturated aldehydes may be prepared by a process comprising treating a b -halogeno-vinyl ether with an alkali-metal amide in liquid ammonia, reacting the resulting liquid ammonia solution containing an alkalimetal derivative of an ethinyl ether with an aldehyde or a ketone, hydrolysing and partially hydrogenating at the triple bond (in either sequence) the reaction product and treating the hydrolysis/partial hydrogenation product so obtained with an acidic agent. Suitable vinyl ethers are for example, b -chloro-vinyl methyl ether, p-chloro-vinyl ethyl ether, b -bromovinyl ethyl ether and b -chloro-vinyl phenyl ether. Suitable aldehydes and ketones are for example propionaldehyde, butyraldehyde, methacrolein, b - methyl - crotonaldehyde, citral, 4 - [21,61,61 - trimethyl - cyclohexen-(11 - yl - (1)] - 2 - methyl - buten - (2) - al - (1); benzaldehyde, cinnamaldehyde, acetone, methyl ethyl ketone, diethyl ketone, mesityl oxide, methyl-heptanone, dimethyl-heptanone, pseudoionone, cyclohexanone, 2,6,6-trimethylcyclohexanone - (1), cyclohexenone, 2,6,6-trimethyl - cyclohexen - (2) - one - (1), dihydrobetaionone, betaionone, 8 - [21,61,61 - trimethylcyclohexen - (1) - yl] - 6 - methyl - octatrien(3,5,7) - one - (2), acetophenone, acetonylacetone, octene - (4) - dione - (2,7), succinic dialdehyde, 2,7 - dimethyl - octatrien - (2,4,6)-dial - (1,8), 2,7 - dimethyl - octadien - (2,6) - in-(4) - dial - (1,8), methoxy - acetone, levulinic acid, p - dimethylamino - benzaldehyde, p-hydroxy - benzaldehyde, androsterone, and oestrone. Preferably the b -halogeno-vinyl ether is a lower alkyl ether, i.e. the alkyl group contains from 1 to 4 carbon atoms, and the acidic agent is a dilute aqueous solution of a mineral acid. The partial hydrogenation of the triple bond may be carried out by adding sodium or lithium to the ammoniacal solution of the condensation product, or by treating the reaction product, after removal of the ammonia, with sodium in damp ether or with lithium aluminium hydride in dry ether, followed by hydrolysis. It is preferred however to carry out the hydrolysis first by the addition of an ammonium salt and to subsequently carry out the partial hydrogenation, for example, by treatment with lithium aluminium hydride in dry ether or by catalytic hydrogenation using a palladium catalyst, advantageously a palladium/calcium - carbonate catalyst partially deactivated by means of lead and quinoline. In the examples: (a) b -chloro-vinyl-ethyl ether is treated with lithium dissolved in liquid ammonia and 4-[21,61,61-trimethyl-cyclohexen-(11) - yl] - 2 - methyl - buten - (2) - al - (1) is added; the resulting mixture is then treated with ammonium chloride and then treated with hydrogen in the presence of a lead-poisoned palladium catalyst to give 6-[21,61,61-trimethyl cyclohexen - (11) - yl] - 4 - methyl - hexadien - (2,4) - al - (1); (b) 6 - methyl - hepten - (5) - one-(2) is added to a mixture of sodium in liquid ammonia and b -chloro-vinyl-ethyl ether and the reaction product is treated with ammonium chloride to give 1-ethoxy-3-hydroxy-3,7-dimethyl - octen - (6) - ine - (1) which is then treated with hydrogen in the presence of a lead-poisoned palladium catalyst to give citral; (c) b -chloro-vinyl ethyl ether is added to a solution of lithium in liquid ammonia and the product is treated with 2,6,6-trimethyl-cyclohexene-(2)-one-(1) (prepared from 2,6,6-trimethyl-cyclohexane by bromination followed by dehydrohalogenation with pyridine); the reaction mixture is then treated with ammonium chloride and the product subsequently treated with hydrogen in the presence of a leadpoisoned palladium catalyst to give [2,6,6-trimethyl - cyclohexen - (2) - ylidine - (1)] - acetaldehyde; (d) in a process similar to that of (c) except that 2,6,6-trimethyl-cyclohexanone is used as starting material the product is [2,6,6-trimethyl - cyclohexylidine - (1)] - acetaldehyde; (e) b -chlor-vinyl ethyl ether is added to a solution of lithium in liquid ammonia and 4 - [21,61, 61 - trimethyl - cyclohexene - (21)-ylidine - (1)1] - 2 - methyl - buten - (2) - al - (1) (prepared by bromination of 4-[21,61,61-trimethyl - cyclohexene - (11) - yl] - 2 - methylbutene - (2) - al - (1), followed by dehydrobromination) is added to the resulting mixture; the reaction mixture is then hydrolysed and partially reduced as in the previous examples to give 6-[21,61,61-trimethyl-cyclohexene-(21) -ylidine - (11)] - 4 - methyl - hexadien - (2,4)-al-(1); (f) in a process similar to that of (e) but using 4 - [21,61,61 - trimethyl - cyclohexadien-(11,31) - yl - (11)] - 2 - methyl - buten - (2) - al-(1) as starting material 6-[21,61,61-trimethylcyclohexadiene - (11,31) - yl - (11)] - 4 - methylhexadien-(2,4)-al-(1) is obtained; (g) in a pro cess similar to that of (e) but using 4-[21,61,61-trimethyl - cyclohexylidine - (11)] - 2 - methylbuten - (2) - al - (1) as starting material, 6 - [21,61,61 - trimethyl - cyclohexylidine - (11)]-4 - methyl - hexadien - (2,4) - al - (1) with a small amount of 6-[21,61,61-trimethyl-cyclohexene - (11) - yl - (11)] - 4 - methyl - hexadien-(2,4)-al-(1) is obtained. The starting material in the last example is prepared by acetalizing (2,6,6 - trimethyl - cyclohexylidine) - acetaldehyde (prepared as in (d) above) with orthoformic acid triethyl ester in the presence of p-toluene sulphonic acid; the resulting (2,6,6:trimethylcyclohexylidine)-acetaldehyde diethyl acetal is condensed with ethyl propenyl ether in the presence of zinc chloride to form 4-[21,61,61-trimethylcyclohexylidine - (11) - 2 - methyl - 1,1,3 - triethoxy-butane which upon hydrolysis-dealcoholation by heating with acetic acid and sodium acetate gives the required 4-[21,61,61 trimethyl - cyclohexylidine - (11)] - 2 - methylbuten - (2) - al - (1). This latter compound may be condensed with isopropenyl acetate to yield 4 - [21,61,61 - trimethyl - cyclohexenyl-(11)] - 2 - methyl - 1 - acetoxy - butadiene - (1,3) which on hydrolysis yields 4-[21,61,61-trimethyl cyclohexen - (11) - yl] - 2 - methyl - buten - (2)-al-(1).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112244039-A
priorityDate 1954-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8079
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420943594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18309
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416047559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539363
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453327643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526927
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414883836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559295
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429272561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18355900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8024
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410691515
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424983022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13594
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449445756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414881231
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID519382
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410000625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420731403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409736587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12367164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID637511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID246728
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1757003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153793927
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21122
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31214
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451203358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407272724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449957047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420266533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415745642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423505225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54438079
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416217425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8125
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3013896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408227676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415709898
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425912215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54543510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489307
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3028194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420291066

Total number of triples: 137.